Workflow
Healthcare Equipment
icon
Search documents
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Zynex, Inc. (ZYXIQ) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
Globenewswire· 2026-02-24 17:32
ATLANTA, Feb. 24, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Zynex, Inc. (“Zynex” or the “Company”) (OTCMKTS: ZYXIQ). The lawsuit alleges that Defendants issued false and misleading statements and/or failed to disclose material adverse facts regarding Zynex’s business, operations, and prospects, including allegations that: (1) Zynex shipped products, including electrodes, in excess of need; (2) as a result of this practice, the Company inflated its revenue; and (3) th ...
OSI Systems Talks $900M Mexico Backlog, U.S. Border Tailwinds and FCF Inflection at Conference
Yahoo Finance· 2026-02-24 12:48
Discussing the “One Big Beautiful Bill,” the CFO said it includes funding for non-intrusive inspection (NII) scanning equipment—OSI’s core offering. He cited approximately $1.0 billion to $1.1 billion allocated for NII and said the company is seeing momentum to move quickly. He also referenced additional funding areas including Border Patrol, biometrics (where OSI believes it is well-positioned), and security for major events such as the Los Angeles Olympics and the World Cup, noting OSI’s work at the Paris ...
Reasons Why Hedge Funds Still Fancy IDEXX Laboratories, Inc. (IDXX)
Yahoo Finance· 2026-02-23 20:48
IDEXX Laboratories, Inc. (NASDAQ:IDXX) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 9, David Westenberg from Piper Sandler maintained his Overweight rating on IDEXX Laboratories, Inc. (NASDAQ:IDXX). The analyst reduced the target price from $775 to $750, which results in a revised upside of 18%. Westenberg’s downward revision of the price target is based on Piper Sandler’s updated multiple for the stock. It also incorporates 2026 projections that have been ...
O5 Adoption Leads to Bullish Views Around Insulet Corporation (PODD)
Yahoo Finance· 2026-02-23 20:46
Insulet Corporation (NASDAQ:PODD) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 4, Stifel lowered its price target on Insulet Corporation (NASDAQ:PODD) from $370 to $350. The firm reiterated a Buy rating on the shares, with a revised upside of almost 45%. The revision was part of its broader 2026 estimates for dental, diabetes, and aesthetics segments. O5 Adoption Leads to Bullish Views Around Insulet Corporation (PODD) On January 27, Mathew Blackman from ...
Abbott Laboratories (ABT) Likely to Benefit From Nutrition Segment Recovery
Yahoo Finance· 2026-02-23 20:41
Abbott Laboratories (NYSE:ABT) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 2, the price target on Abbott Laboratories (NYSE:ABT) was reduced from $169 to $142 by Barclays analyst Matt Miksic. The analyst reiterated his Overweight rating on the stock, which offers a revised upside potential of almost 27%. Abbott Laboratories (ABT) Likely to Benefit From Nutrition Segment Recovery Miksic’s revisions were based on deflated forecasts and target multiple for ...
Da Vinci 5 Sparks Optimism Around Intuitive Surgical, Inc. (ISRG)
Yahoo Finance· 2026-02-23 20:37
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On January 27, Freedom Capital increased the price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) from $560 to $610, and also upgraded its rating on the stock from Hold to Buy. The upward revision in the target price now leads to more than 11% upside potential at the prevailing level. Da Vinci 5 Sparks Optimism Around Intuitive Surgical, Inc. (ISRG) The firm attributed its rating u ...
Medtronic plc (MDT) Gains Momentum Through Diabetes and Cardiovascular Operations
Yahoo Finance· 2026-02-23 20:33
Core Insights - Medtronic plc (NYSE:MDT) is recognized as one of the top 10 healthcare equipment stocks favored by hedge funds [1] - The company operates in four segments: Cardiovascular, Diabetes, Medical-Surgical, and Neuroscience, addressing over 70 chronic diseases [3] Analyst Ratings and Price Targets - Truist analyst Richard Newitter reduced the price target for Medtronic from $107 to $103 while maintaining a Hold rating, citing modest organic revenue and a slight EPS beat [1] - Barclays analyst Matt Miksic maintained an Overweight rating and increased the price target from $116 to $118, indicating a potential upside of nearly 22% [2] Performance Highlights - Medtronic reported solid performance, exceeding street expectations in three out of four segments, with notable strength in the Diabetes and Cardiovascular divisions [1] - The stock's reaction to the earnings beat was moderated by preliminary commentary on potential challenges for fiscal 2027 [2]
Here's Walmart's $1 trillion secret
Yahoo Finance· 2026-02-22 13:30
Company Insights - Phoebe Gates, daughter of Microsoft co-founder Bill Gates, has launched a new startup called Phia, which is an AI-powered shopping assistant aimed at reducing clothing shopping time [2] - Nextdoor's founder Nirav Tolia defended the company's quarterly performance, indicating a commitment to transparency and research in earnings releases [3] - Figma's CFO Praveer Melwani expressed confidence in the company's ability to thrive in the AI era, suggesting positive prospects based on Q4 results [3] - Bausch & Lomb's CEO Brent Saunders announced a breakthrough in contact lens innovation and linked employee bonuses to AI literacy, highlighting the importance of AI in the company's future [4] Industry Trends - The integration of AI in various sectors is expected to significantly impact corporate structures, with predictions that many corporate offices may be streamlined by 2030 due to AI advancements [5] - Walmart's recent earnings report emphasized the role of technology in enhancing operational efficiency, particularly through the use of robots in factories and improved delivery times, including same-day delivery becoming standard [7][8] - Walmart's listing on the tech-heavy Nasdaq Composite marks a strategic shift, with executives discussing the importance of technology during earnings calls [8]
OSI Systems (NasdaqGS:OSIS) 2026 Conference Transcript
2026-02-19 19:02
Summary of OSI Systems Conference Call Company Overview - **Company**: OSI Systems - **Divisions**: Three main divisions - Security, Optoelectronics, and Healthcare - **Security Division**: Largest, over two-thirds of revenue, focuses on security detection for cargo, vehicle inspection, and aviation - **Healthcare Division**: Smallest, sells patient monitoring and cardiology equipment, with about half of its revenue being recurring - **Optoelectronics Division**: Supplies sensors and electronic components to OEMs across various industries, representing about a quarter of revenues [2][4][5] Key Points and Arguments Security Division Growth - Recent growth driven by international contracts, particularly in Mexico, with three contracts totaling approximately $900 million expected to generate significant revenue in fiscal 2024 and 2025 [7] - Anticipated shift towards stronger domestic growth in the U.S., driven by border initiatives and substantial orders from Customs and Border Protection (CBP) [9][10] - The "One Big Beautiful Bill" allocates $1-$1.1 billion for Non-Intrusive Inspection (NII) scanning equipment, which aligns with OSI's offerings [12] - Historical success with CBP, capturing 40%-45% of overall awards, positioning OSI favorably for future contracts [14] Competitive Landscape - Main competitors include Leidos and Smiths Detection, with OSI's broad technology approach providing a competitive edge [20][22] - OSI's strategy includes combining various technologies to offer tailored solutions, enhancing market share in cargo and vehicle inspection [22][23] AI and Technology Integration - OSI has incorporated AI into its products, positioning itself as an early adopter in the industry, with ongoing investments in R&D for product development and cybersecurity [25] Golden Dome Initiative - OSI is well-positioned for the Golden Dome initiative, having acquired RF technology that aligns with the program's requirements [30] - The company is expanding manufacturing capacity in Texas to support anticipated growth from this initiative [31] Revenue and Margin Dynamics - Service revenue is growing at an accelerated rate, with margins over 10 percentage points higher than product revenue, leading to overall operating margin expansion [33][35] - Transitioning to a "security as a service" model, allowing for long-term contracts and recurring revenue at higher margins [38][39] International Market Presence - Strong presence in the Middle East, EU, UK, and Latin America, with significant growth opportunities in India and other regions [55][56] - Demand driven by global security concerns and the need for automated security solutions [61][62] Healthcare Division Outlook - New leadership and significant R&D investments are expected to enhance the healthcare division, which has the highest contribution margins among OSI's divisions [134] Financial Health and Cash Flow - Anticipated inflection point in free cash flow generation due to strong profits and normalization of accounts receivable from contracts in Mexico [115] - Clean balance sheet with modest net leverage, allowing for potential acquisitions while maintaining financial stability [136] Other Important Insights - OSI's unique approach to combining product sales with service contracts has created a robust recurring revenue model, enhancing customer retention and long-term profitability [80] - The company is focused on strategic M&A to complement organic growth, emphasizing the importance of selecting the right opportunities [105][111] Conclusion - OSI Systems is positioned for significant growth driven by domestic and international opportunities, technological advancements, and a strong focus on recurring revenue models, with a clean balance sheet supporting future investments and acquisitions [138]
X @Bloomberg
Bloomberg· 2026-02-18 03:55
Bain Capital and UBS are lending a combined $382 million to an Australian health-equipment manufacturer Aidacare, sources say, in the latest example of private credit being used to help finance stakeholder returns https://t.co/BneV9EZwr1 ...